Search results

...cription|Online information service produced by the US National Library of Medicine}} ...ne information service produced by the [[United States National Library of Medicine]]. The service provides [[content curation|curated]] consumer health inform ...

...rl=https://www.whocc.no/atc_ddd_alterations__cumulative/ddd_alterations/ | access-date=27 December 2019}}</ref> ...fferent groups according to the organ or system on which they act, their [[medicine|therapeutic]] intent or nature, and the drug's [[chemical classification|ch ...

...CASRNs|url=http://www.cas.org/expertise/cascontent/registry/regsys.html#q2|access-date=25 July 2009|archive-url=https://web.archive.org/web/20080725010848/ht ...mation |url=https://www.cas.org/resources/press-releases/common-chemistry |access-date=17 March 2021 |work=CAS |language=en}}</ref> ...

{{Short description|System of Chinese medicine in Japan}} |l="Han [Chinese] medicine in Japan" ...

{{Short description|System of Chinese medicine in Japan}} |l="Han [Chinese] medicine in Japan" ...

肥満には社会的スティグマがあるため、肥満の人は正常な[[Body mass index/ja|BMI]] 体重の範囲内の人よりも貧しい医療を受ける可能性があり、肥満と悪い健康転帰の関係を助長している可能性がある。実際の体重の状態に関係なく [[carpal tunnel syndrome/ja|手根管症候群]]のリスクは、[[body mass index/ja|肥満度]]が1 kg/m²増加するごとに7.4%上昇すると推定されている。 ...

{{Redirect/ja|Medicines/ja||Medicine (disambiguation)/ja|と|Medication (disambiguation)/ja}} | synonyms = Medicine, drug, pharmaceutical, pharmaceutical preparation, pharmaceutical product, ...

...29.9) may actually be lower than for those with an ideal weight (BMI 18.5 to 24.9). Health risks for those who are overweight may be decreasing over tim ...e weight-related discrimination. People who are obese are also less likely to seek medical care than people who are not obese, even if the weight gain is ...

...PHARMACOLOGY |url=https://www.merriam-webster.com/dictionary/pharmacology |access-date=2023-02-28 |website=Merriam-Webster |language=en}}</ref> If substances ...ffects and the elucidation of cellular and organismal function in relation to these chemicals. In contrast, pharmacy, a health services profession, is co ...

...29.9) may actually be lower than for those with an ideal weight (BMI 18.5 to 24.9). Health risks for those who are overweight may be decreasing over tim ...e weight-related discrimination. People who are obese are also less likely to seek medical care than people who are not obese, even if the weight gain is ...

...a|抗糖尿病薬]]（[[metformin/ja|メトホルミン]]や[[semaglutide/ja|セマグルチド]]など）や[[Lifestyle medicine/ja|生活習慣の改善]]が用いられる。[[Gestational diabetes/ja|妊娠糖尿病]]は、一部の女性において[[pregnancy/ | 0.69 to 0.88|| 0.47 to 0.77 ...

[[:en:London Stock Exchange|ロンドン証券取引所]]に一次上場しており、[[:en:FTSE 100 Index|FTSE100指数]]の構成銘柄となっている。2016年8月現在、時価総額は810億ポンド（約1070億米ドル）で、ロンドン証券取引所では4番目の規模 ...otograph|[[Wikipedia:Andrew Witty|Andrew Witty]], GSK's CEO from May 2008, to April 2017]] ...

...for Health and Clinical Excellence|米国国立医療技術評価機構]]は2004年に、PCOSで[[body mass index/ja|肥満度]]が25を超える女性に対して、他の治療法で効果が得られない場合に[[anovulation/ja|無排卵]]と[[infertility ...拮抗薬]]はメトホルミンの血漿中濃度を上昇させる。[[cimetidine/ja|シメチジン]]は、腎臓によるメトホルミンの[[clearance (medicine)/ja|クリアランス]]を低下させることにより、メトホルミンの血漿中濃度の上昇を引き起こす；メトホルミンとシメチジンはどちらも[[Renal phys ...

...ies on [[canagliflozin]], a member of this class, the medication was found to enhance blood sugar control as well as reduce [[body weight]] and systolic ...e beneficial in persons with higher eGFR. Likewise, the risk reduction due to SGLT-2 inhibitors was larger in populations with a higher proportion of [[a ...

{{short description|Substance used to diagnose, cure, treat, or prevent disease}} {{Redirect|Medicines||Medicine (disambiguation)|and|Medication (disambiguation)}} ...

...ies on [[canagliflozin]], a member of this class, the medication was found to enhance blood sugar control as well as reduce [[body weight]] and systolic ...e beneficial in persons with higher eGFR. Likewise, the risk reduction due to SGLT-2 inhibitors was larger in populations with a higher proportion of [[a ...

...のみを代謝するものもあれば、複数の[[Substrate (biochemistry)/ja|基質]]を代謝するものもある。これらの特徴の両方が、[[medicine/ja|医学]]における中心的な重要性の理由である。シトクロムP450酵素は身体のほとんどの組織に存在し、[[hormone/ja|ホルモン]]の合成と ...な薬物相互作用は、患者にとって極めて重要な薬物、重大な[[adverse effect/ja|副作用]]を伴う薬物、または[[therapeutic index/ja|治療指数]]の狭い薬物を使用する場合に特に考慮する必要があるが、どのような薬物でも薬物代謝の変化により血漿中濃度が変化する可能性がある。 ...

| diagnosis = [[Body mass index/ja|BMI]] > {{val|30|ul=kg/m2}} ...ぼす可能性があるほど蓄積している医学的状態であり、時に[[disease/ja|病気]]とみなされる。体重を身長の2乗で割った[[Body mass index/ja|体格指数]]（BMI）が{{val|30|ul=kg/m2}}を超えると肥満と分類され、{{val|25|–|30|ul=kg/m2}}の範囲が ...

{{short description|Substance used to diagnose, cure, treat, or prevent disease}} {{Redirect|Medicines||Medicine (disambiguation)|and|Medication (disambiguation)}} ...

...contact lens]]es, [[Wikipedia:Veterinary medicine|animal health|Veterinary medicine|animal health]] ([[#Products|list...]]) ...きるようにしているかで企業を評価する「[[Wikipedia:Access to Medicine Index|Access to Medicine Index]]」で2位にランクされている。 ...